Cardiol Therapeutics Inc. Class ACRDL
13F holders, Q1 2024 (March 31)35holders
1famous investor
$1.79avg. 13F price*
At the end of Q1 2024, 35 institutions reported holding Cardiol Therapeutics Inc. Class A (CRDL) in their 13F filings. The largest holders were MMCAP International Inc. SPC ($4.6M), Tejara Capital Ltd ($3.0M) and AdvisorShares Investments LLC ($2.4M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cardiol Therapeutics Inc. Class A
- CUSIP
- 14161Y200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $293K |
| Exits | 3 | $584K |
Ownership 35 holders
| MMCAP International Inc. SPC | 0.61% | Reduce -13.1% | 2,566,125 | $4.6M |
| Tejara Capital Ltd | 1.10% | Add +47.3% | 1,644,410 | $3.0M |
| AdvisorShares Investments LLC | 0.43% | Add +9.4% | 1,301,978 | $2.4M |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +51.1% | 128,743 | $233K |
| Credit Suisse AG/ | 0.00% | No change | 80,000 | $194K |
| Laird Norton Wetherby Trust Company, LLC | 0.02% | No change | 100,000 | $181K |
| Mgo One Seven LLC | 0.01% | No change | 100,000 | $181K |
| Lion Street Advisors, LLC | 0.07% | No change | 192,700 | $161K |
| Citadel Advisors | 0.00% | New | 60,398 | $109K |
| Bank of Montreal | 0.00% | Reduce -52.1% | 50,000 | $105K |
| Geode Capital Management, LLC | 0.00% | No change | 52,435 | $95K |
| Susquehanna International Group, LLP | 0.00% | New | 45,669 | $83K |
| Marble Harbor Investment Counsel, LLC | 0.01% | No change | 36,900 | $67K |
| Osaic Holdings, Inc. | 0.00% | Reduce -61.7% | 25,600 | $46K |
| Envestnet Asset Management Inc. | 0.00% | New | 25,380 | $46K |
| Goldman Sachs Group Inc. | 0.00% | No change | 23,500 | $43K |
| Royal Bank of Canada | 0.00% | Reduce -51.8% | 16,429 | $31K |
| Two Sigma Advisers, LP | 0.00% | Reduce -2.4% | 16,500 | $30K |
| Private Ocean, LLC | 0.00% | No change | 15,151 | $27K |
| Two Sigma Securities, LLC | 0.00% | New | 14,681 | $27K |
| Townsquare Capital LLC | 0.00% | New | 12,661 | $23K |
| Raymond James & Associates | 0.00% | No change | 11,154 | $20K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 6,900 | $17K |
| Valley National Advisers Inc. | 0.00% | No change | 5,000 | $9K |
| Bank of America Corp. | 0.00% | No change | 4,000 | $7K |
| Group One Trading LLC | 0.00% | No change | 3,667 | $7K |
| Piscataqua Savings Bank | 0.01% | No change | 3,000 | $6K |
| Wells Fargo & Company | 0.00% | New | 3,000 | $5K |
| UBS Group AG | 0.00% | Reduce -51.3% | 2,781 | $5K |
| National Bank of Canada | 0.00% | Add +6.0% | 2,120 | $5K |
| Benjamin Edwards Inc. | 0.00% | No change | 875 | $2K |
| Rise Advisors, LLC | 0.00% | No change | 1,000 | $2K |
| SouthState Bank Corp | 0.00% | No change | 1,000 | $2K |
| City State Bank | 0.00% | No change | 825 | $1K |
| Toronto Dominion Bank | 0.00% | Reduce -55.8% | 103 | $186 |
"% of holder's portfolio" is CRDL's weight in each manager's 13F, not the share of Cardiol Therapeutics Inc. Class A the manager owns.